Oura Shifts Wearables to Hormonal Context

Oura's "Cycle Insights" feature utilizes biomarkers like body temperature trends, heart rate variability, and resting heart rate to identify follicular and luteal phases, moving beyond simple period tracking. This allows for more personalized insights into how an individual's cycle affects their entire body, with an ovulation prediction algorithm trained on over 42 million nights of sleep data. The company, led by CEO Tom Hale, is focusing on longevity and a broader definition of health rather than just peak performance. This deeper analysis of hormonal fluctuations is part of a larger trend in the women's digital health market, which was valued at over $524 million for wearable devices in 2023 and is projected to grow significantly. Competitors are also advancing their offerings. Apple integrated cycle tracking into the Health app and Apple Watch, using logged data and wrist temperature for predictions. Whoop's "Hormonal Insights" feature provides coaching on sleep and strain based on menstrual cycle phases and also offers pregnancy-specific tracking. Oura is further personalizing its platform by developing its first proprietary large language model for women's health, currently being tested in Oura Labs. This AI model is designed to answer questions across the reproductive health spectrum, from menstruation to menopause, by integrating biometric data with clinically reviewed information. This move comes as surveys show a growing number of people are turning to AI for health information. The company's strategy under CEO Tom Hale extends beyond a single device, aiming to create a "Personal Health OS" that integrates various data inputs. This vision includes recent acquisitions and partnerships to incorporate glucose monitoring, reflecting a shift toward a comprehensive health analytics platform. This positions Oura as a health hub for both consumers and potentially clinicians, emphasizing the importance of user trust and data privacy.